Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States

Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States

Antimicrobial resistance is a global public health threat, and gram-negative bacteria, such as Enterobacterales and <i>Pseudomonas aeruginosa,</i> are particularly problematic with difficult-to-treat resistance phenotypes. To reduce morbidity and mortality, a reduction in the time to eff...

Full description

Bibliographic Details
Main Authors: Kenneth P. Klinker, Levita K. Hidayat, Eric Wenzler, Joan-Miquel Balada-Llasat, Mary Motyl, C. Andrew DeRyke, Karri A. Bauer
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Antibiotics
Subjects:
syndromic antibiogram
susceptibility testing
Enterobacterales
<i>Pseudomonas aeruginosa</i>
extended-spectrum β-lactamase
cefepime
Online Access:https://www.mdpi.com/2079-6382/11/5/660

Internet

https://www.mdpi.com/2079-6382/11/5/660

Similar Items